Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The objectives of the present study aims to evaluate the safety and efficacy of Silodosin in
a population of patients wih Premature Ejaculation (PE). Coupled with efficient diagnosis, it
is hoped that the newer agent will improve the quality of life for patients who suffer from
Premature Ejaculation (PE).
Phase:
Phase 2
Details
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation